Search Results

al. 1997 ), the acid labile subunit (ALS) of the IGF binding complex ( Ooi et al. 1997 ), serine protease inhibitor (Spi) 2.1 ( Yoon et al. 1990 ), suppressors of cytokine signaling (SOCS) genes ( Tollet-Egnell et al. 1999 ), phosphoenol

( Peinnequin et al. 2004 ), suppressor of cytokine signaling-3 (SOCS-3) forward: CCTCCAG-CATCTTTGTCGGAAGAC; SOCS-3 reverse: TACTGG-TCCAGGAACTCCCGAATG; hypoxanthine–guanine phosphorybosyl transferase (Hprt) forward: CTCATG-GACTGATTATGGACAGGAC; Hprt reverse

in adipose tissue and hepatic tissue, IL6 is shown to be a pro-inflammatory adipokine. It increases insulin resistance by up-regulating suppressor of cytokine signalling 3 (SOCS3), which, in turn, impairs insulin-induced insulin receptor and IRS1

-Haschimi et al . 2000 ), impaired leptin signaling by suppressor of cytokine signaling 3 (SOCS3; Bjorbaek et al . 1998 , Dunn et al . 2005 ), impaired leptin receptor trafficking ( Bjornholm et al . 2007 , Morrison et al . 2007 ), saturation of leptin

, a decrease in Akt activation through an increase in suppressor of cytokine signaling (SOCS3) was linked to an inefficient leptin signaling ( King et al . 2018 ). Figure 2 Scheme of potential neuroprotective effects of anorexigenic peptides

members of the suppressor of cytokine signalling (SOCS) family. Currently the SOCS family consists of eight members (SOCS1–7 and cytokine-inducible SH2-containing domain (CIS)); the role of SOCS4–7 in cytokine signalling has received limited attention. The

.mrrev.2009.01.001 ) Wu WY Kim H Zhang CL Meng XL Wu ZS 2014 Loss of suppressors of cytokine signaling 3 promotes aggressiveness in hepatocellular carcinoma . Journal of Investigative Surgery 27 197 – 204 . ( doi:10

  EMR1 2015 207111_at −2.0 0.185 EGF-like module containing, mucin-like, hormone receptor-like 1   SOCS3 9021 227697_at −1.9 0.198 Suppressor of cytokine signalling 3   LRP12 29 967 220254_at −1.9 0.143 Low density lipoprotein-related protein 12   RGS17

neuropeptide Y ( Npy ) and agouti related peptide ( Agrp ) and in the appetite-suppressing melanocortin pathway ( Huang et al . 2003 a , b ) were the predominant contributors, whereas other authors showed changes only in the suppressor of cytokine signalling 3

context, breast cancer cells overexpressing the estrogen receptor ( Boerner et al . 2005 ). The activation of the STATs is highly regulated but incompletely understood. GRB2 and suppressors of cytokine signaling (SOCS) can inhibit STAT-mediated EGFR